chr9:21367372:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr9:21,367,371-21,368,056 |
hg38 | chr9:21,367,372-21,368,057 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | celiac disease | NA | BeFree | Detail | |
<0.001 | Chikungunya Fever | NA | BeFree | Detail | |
<0.001 | choriocarcinoma | NA | BeFree | Detail | |
<0.001 | colitis | NA | BeFree | Detail | |
<0.001 | ulcerative colitis | NA | BeFree | Detail | |
<0.001 | colorectal carcinoma | NA | BeFree | Detail | |
<0.001 | common variable immunodeficiency | NA | BeFree | Detail | |
<0.001 | Coronary Arteriosclerosis | The results argue against the potential utility of drugs targeting type-I IFN pr... | BeFree | 25882064 | Detail |
<0.001 | Coronary heart disease | The results argue against the potential utility of drugs targeting type-I IFN pr... | BeFree | 25882064 | Detail |
<0.001 | cryoglobulinemia | NA | BeFree | Detail | |
<0.001 | cystic fibrosis | NA | BeFree | Detail | |
<0.001 | Cytomegalovirus Infections | NA | BeFree | Detail | |
<0.001 | Hepatitis D Infection | NA | BeFree | Detail | |
0.001 | Dengue Fever | NA | BeFree | Detail | |
0.001 | dermatomyositis | NA | BeFree | Detail | |
<0.001 | dermoid cyst | NA | BeFree | Detail | |
0.001 | Diabetes | NA | BeFree | Detail | |
0.001 | diabetes mellitus | NA | BeFree | Detail | |
0.001 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree | Detail | |
<0.001 | Down syndrome | NA | BeFree | Detail | |
<0.001 | Muscular Dystrophy, Duchenne | NA | BeFree | Detail | |
<0.001 | Ectromelia | We showed that DC are the primary producers of type I interferons (T1-IFN), requ... | BeFree | 26202250 | Detail |
<0.001 | encephalitis | NA | BeFree | Detail | |
<0.001 | Japanese encephalitis | Delayed IFN response differentiates replication of West Nile virus and Japanese ... | BeFree | 25920530 | Detail |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
<0.001 | Venezuelan equine encephalomyelitis | NA | BeFree | Detail | |
<0.001 | Enterovirus Infections | Our results suggest that enterovirus-induced miR-146a facilitates viral pathogen... | BeFree | 24561744 | Detail |
<0.001 | Eosinophilia | NA | BeFree | Detail | |
<0.001 | erythromelalgia | NA | BeFree | Detail | |
0.001 | Fanconi anemia | NA | BeFree | Detail | |
<0.001 | Fatigue | NA | BeFree | Detail | |
<0.001 | Fatty Liver | Hepatic steatosis is a risk factor for both liver disease progression and an imp... | BeFree | 25961570 | Detail |
<0.001 | Foot-and-Mouth Disease | NA | BeFree | Detail | |
<0.001 | gingivitis | NA | BeFree | Detail | |
0.002 | glioblastoma | We have previously shown that cysteine-rich 61 protein (CCN1) activates a type 1... | BeFree | 24895995 | Detail |
0.002 | glioblastoma | Delayed IFN response differentiates replication of West Nile virus and Japanese ... | BeFree | 25920530 | Detail |
0.002 | Glioma | NA | BeFree | Detail | |
<0.001 | Graft-vs-Host Disease | NA | BeFree | Detail | |
<0.001 | hand, foot and mouth disease | Those with mild HFMD had higher γ-IFN expression levels compared with those with... | BeFree | 25059424 | Detail |
<0.001 | Hematological Disease | NA | BeFree | Detail | |
<0.001 | Severe Dengue | NA | BeFree | Detail | |
0.002 | hepatitis | The identification of mutations in the HVR1 region of hepatitis type C virus (HC... | BeFree | 25588648 | Detail |
0.003 | hepatitis A | The identification of mutations in the HVR1 region of hepatitis type C virus (HC... | BeFree | 25588648 | Detail |
0.014 | hepatitis B | For HBeAg-positive patients and HBeAg-negative patients with genotype D infectio... | BeFree | 24738850 | Detail |
0.014 | hepatitis B | The study of on-treatment dynamics of HBV infection by means of combined quantit... | BeFree | 25034484 | Detail |
0.014 | hepatitis B | Then, we aimed to investigate the role of CYP27B1 polymorphisms in HBV treatment... | BeFree | 25060765 | Detail |
0.014 | hepatitis B | A total of 30 patients with CHB who achieved HBsAg seroclearance following peg-I... | BeFree | 25324041 | Detail |
0.014 | hepatitis B | In SVR to Peg-IFN/NUCs MiR-B-Index improved during-therapy and post-treatment re... | BeFree | 25350115 | Detail |
0.014 | hepatitis B | A total of 210 patients with chronic hepatitis C genotype 1 of high viral load (... | BeFree | 25914481 | Detail |
0.002 | Hepatitis, Chronic | NA | BeFree | Detail | |
0.030 | hepatitis C | The next phase of therapy will be combining several classes of DAAs without IFN ... | BeFree | 24636306 | Detail |
0.030 | hepatitis C | For patients infected with hepatitis C virus (HCV), the combination of the direc... | BeFree | 25101970 | Detail |
0.030 | hepatitis C | In addition, the results suggest new viral genomic attributes that might influen... | BeFree | 25150834 | Detail |
0.030 | hepatitis C | Noncirrhotic HCV treatment-naive patients and prior relapsers received response-... | BeFree | 25192745 | Detail |
0.030 | hepatitis C | Optimizing triple therapy and IFN/RBV-free regimens for hepatitis C virus infect... | BeFree | 25220206 | Detail |
0.030 | hepatitis C | In May 2011, boceprevir and telaprevir, two first-generation NS3/4A protease inh... | BeFree | 25229466 | Detail |
0.030 | hepatitis C | Treatment of hepatitis C virus (HCV) with pegylated interferon and ribavirin (IF... | BeFree | 25326107 | Detail |
0.030 | hepatitis C | This review will focus on the second-wave DAAs including protease inhibitors (PI... | BeFree | 25529082 | Detail |
0.030 | hepatitis C | Forty patients infected with hepatitis C virus (HCV) genotype 1 and starting ant... | BeFree | 25583751 | Detail |
0.030 | hepatitis C | Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in ch... | BeFree | 25599750 | Detail |
0.030 | hepatitis C | Impaired induction of IL28B, related to IFNλ4 expression in PBMCs of IL28B-unfav... | BeFree | 25611696 | Detail |
0.030 | hepatitis C | Here, we discuss IFN-λ genetic polymorphisms and their role in HCV and other inf... | BeFree | 25634147 | Detail |
0.030 | hepatitis C | IFN-free regimens with direct antiviral agents (DAAs) against hepatitis C virus ... | BeFree | 25645644 | Detail |
0.030 | hepatitis C | Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C a... | BeFree | 25650729 | Detail |
0.030 | hepatitis C | In this contest IFN-α therapy, a standard therapy for HCV-infection and lymphopr... | BeFree | 25700262 | Detail |
0.030 | hepatitis C | These findings expand our understanding of IFN-responses in HCV-infected individ... | BeFree | 25765354 | Detail |
0.030 | hepatitis C | We conducted an open-label trial to assess the efficacy and safety of sofosbuvir... | BeFree | 25847509 | Detail |
0.030 | hepatitis C | Between January 2006 and June 2012, a total of 180 patients with chronic infecti... | BeFree | 25852275 | Detail |
0.030 | hepatitis C | A total of 210 patients with chronic hepatitis C genotype 1 of high viral load (... | BeFree | 25914481 | Detail |
0.030 | hepatitis C | Hepatitis C virus (HCV) genotype 1 infections are significantly more difficult t... | BeFree | 25965701 | Detail |
0.030 | hepatitis C | To assess the accuracy and cost-effectiveness of the automated Abbott ARCHITECT ... | BeFree | 26018116 | Detail |
0.030 | hepatitis C | We demonstrated a marked polarization of NK cells toward cytotoxicity in respons... | BeFree | 26034208 | Detail |
0.030 | hepatitis C | Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cry... | BeFree | 26060059 | Detail |
0.030 | hepatitis C | Sixty-one patients under suppressive antiretroviral therapy were included: 37 wi... | BeFree | 26181704 | Detail |
0.004 | Herpes Simplex Infections | NA | BeFree | Detail | |
<0.001 | Herpesviridae Infections | NA | BeFree | Detail | |
0.020 | HIV Infections | The OPERA study results show that PEG-IFN plus ribavirin is an effective treatme... | BeFree | 24583976 | Detail |
0.020 | HIV Infections | We modeled increased activation in HIV infection by priming human monocytes with... | BeFree | 24731171 | Detail |
0.020 | HIV Infections | To determine SVR and other response rates, identify SVR predictors and analyse d... | BeFree | 25041136 | Detail |
0.020 | HIV Infections | The specific reduction of miR-422a is associated with exogenous IFN-α treatment,... | BeFree | 25275557 | Detail |
0.020 | HIV Infections | In sum, we identified a novel mechanism of HIV-1-induced CXCL13 secretion-one ca... | BeFree | 25667414 | Detail |
0.020 | HIV Infections | Blimp-1 binds an IFN-stimulated response element within HIV-1 provirus, and it i... | BeFree | 25710909 | Detail |
0.020 | HIV Infections | The results suggest that the presence of the IFN+874A allele confers susceptibil... | BeFree | 25802474 | Detail |
0.020 | HIV Infections | Group 1 comprised HIV/HCV co-infected patients who were treated with highly acti... | BeFree | 25823618 | Detail |
0.020 | HIV Infections | These novel findings will be of great interest to those working on the roles of ... | BeFree | 25972534 | Detail |
<0.001 | Hypertension, Portal | NA | BeFree | Detail | |
<0.001 | pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Immune System Diseases | NA | BeFree | Detail | |
0.004 | influenza | The increased level of IFN-λ mRNA corresponded to significantly increased level ... | BeFree | 26104331 | Detail |
<0.001 | ischemia | NA | BeFree | Detail | |
<0.001 | Kidney Diseases | NA | BeFree | Detail | |
<0.001 | Kidney Failure, Chronic | NA | BeFree | Detail | |
<0.001 | leprosy | NA | BeFree | Detail | |
0.002 | leukemia | NA | BeFree | Detail | |
<0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | hairy cell leukemia | NA | BeFree | Detail | |
<0.001 | lymphoid leukemia | NA | BeFree | Detail | |
0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
<0.001 | myeloid leukemia | NA | BeFree | Detail | |
0.005 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
0.001 | Leukemia, Myeloid, Chronic-Phase | NA | BeFree | Detail | |
<0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
<0.001 | leukopenia | Logistic regression analysis showed that rs2305482 CC and neutrophil count at ba... | BeFree | 25515861 | Detail |
<0.001 | lichen planus | NA | BeFree | Detail | |
0.005 | liver cirrhosis | Of 326 patients with HCV-related chronic liver disease (252 with genotype 1b and... | BeFree | 24065124 | Detail |
0.005 | liver cirrhosis | The recent October 2014 approval of the fixed dose combination (FDC) of the NS5B... | BeFree | 25676581 | Detail |
0.003 | Liver diseases | Hepatic steatosis is a risk factor for both liver disease progression and an imp... | BeFree | 25961570 | Detail |
0.001 | Liver neoplasms | NA | BeFree | Detail | |
<0.001 | Lung diseases | NA | BeFree | Detail | |
<0.001 | Lung Neoplasms | NA | BeFree | Detail | |
0.006 | Lupus Vulgaris | Persistent production of IFN-α, the most abundant subtype measured in these pati... | BeFree | 25468480 | Detail |
<0.001 | Lupus Erythematosus, Cutaneous | NA | BeFree | Detail | |
0.006 | Lupus Erythematosus, Discoid | Persistent production of IFN-α, the most abundant subtype measured in these pati... | BeFree | 25468480 | Detail |
<0.001 | lupus nephritis | NA | BeFree | Detail | |
<0.001 | Lyme disease | RST1 isolates, which are more frequently associated with disseminated Lyme disea... | BeFree | 24945497 | Detail |
<0.001 | lymphoma | NA | BeFree | Detail | |
<0.001 | Lymphoproliferative Disorders | In this contest IFN-α therapy, a standard therapy for HCV-infection and lymphopr... | BeFree | 25700262 | Detail |
<0.001 | malaria | Interferon-γ (IFNG) microsatellite repeat and single nucleotide polymorphism hap... | BeFree | 25445652 | Detail |
<0.001 | Malaria, Cerebral | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
0.001 | measles | NA | BeFree | Detail | |
0.014 | melanoma | Expression of the IFITM proteins was found to delay the phosphorylation of IFN r... | BeFree | 25228491 | Detail |
0.014 | melanoma | Baseline expression of PD-L1 by melanoma cell lines was virtually nil, regardles... | BeFree | 25370533 | Detail |
0.014 | melanoma | Serum samples from 275 high-risk melanoma patients enrolled in the Nordic Adjuva... | BeFree | 25832001 | Detail |
<0.001 | Mesothelioma | NA | BeFree | Detail | |
0.001 | mitral valve stenosis | NA | BeFree | Detail | |
0.003 | multiple myeloma | NA | BeFree | Detail | |
0.004 | multiple sclerosis | A multiple sclerosis-associated variant of CBLB links genetic risk with type I I... | BeFree | 25261476 | Detail |
<0.001 | mumps | Induction of IFN-α subtypes and their antiviral activity in mumps virus infectio... | BeFree | 25361048 | Detail |
<0.001 | myasthenia gravis | NA | BeFree | Detail | |
0.002 | Mycobacterium Infections | NA | BeFree | Detail | |
<0.001 | Mycoses | NA | BeFree | Detail | |
<0.001 | Myeloproliferative disease | NA | BeFree | Detail | |
<0.001 | myocarditis | NA | BeFree | Detail | |
<0.001 | myositis | NA | BeFree | Detail | |
<0.001 | Nasal Polyps | NA | BeFree | Detail | |
0.003 | Neoplasm Metastasis | Conversely, the IFN metagene was associated with a low risk of metastasis in 104... | BeFree | 24853384 | Detail |
0.003 | Neoplasm Metastasis | These results provide evidence supporting that EMT activation and IFN pathway in... | BeFree | 25001613 | Detail |
0.003 | Neoplasm Metastasis | Overall, our findings describe a novel role for IFN during metastasis developmen... | BeFree | 25604426 | Detail |
0.002 | neuroblastoma | Delayed IFN response differentiates replication of West Nile virus and Japanese ... | BeFree | 25920530 | Detail |
<0.001 | neutropenia | Logistic regression analysis showed that rs2305482 CC and neutrophil count at ba... | BeFree | 25515861 | Detail |
<0.001 | obesity | NA | BeFree | Detail | |
<0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
<0.001 | osteomyelitis | NA | BeFree | Detail | |
0.001 | osteosarcoma | NA | BeFree | Detail | |
0.001 | ovarian carcinoma | NA | BeFree | Detail | |
<0.001 | papilloma | NA | BeFree | Detail | |
<0.001 | bullous pemphigoid | NA | BeFree | Detail | |
<0.001 | periodontitis | NA | BeFree | Detail | |
<0.001 | Peripheral neuropathy | NA | BeFree | Detail | |
<0.001 | Pituitary Neoplasms | NA | BeFree | Detail | |
<0.001 | plasmacytoma | NA | BeFree | Detail | |
<0.001 | Pneumococcal Infections | NA | BeFree | Detail | |
0.002 | polycythemia vera | NA | BeFree | Detail | |
<0.001 | Post-kala-azar dermal leishmaniasis | Uniformly low expression of IFN and IFNGR1 in PKDL skin biopsies could explain p... | BeFree | 25466928 | Detail |
<0.001 | progeria | NA | BeFree | Detail | |
<0.001 | Prostatic Neoplasms | NA | BeFree | Detail | |
0.001 | psoriasis | In contrast, other antimicrobial peptides expressed in psoriatic skin including ... | BeFree | 25332209 | Detail |
<0.001 | kidney failure | NA | BeFree | Detail | |
0.003 | Respiratory Syncytial Virus Infections | Furthermore, knocking down the endogenous and IFN-induced expression of IFITM1 a... | BeFree,GAD | 25228491 | Detail |
<0.001 | Respiratory Tract Infections | NA | BeFree | Detail | |
<0.001 | Retroviridae Infections | NA | BeFree | Detail | |
<0.001 | Rheumatism | NA | BeFree | Detail | |
<0.001 | RNA Virus Infections | NA | BeFree | Detail | |
<0.001 | Rotavirus Infections | NA | BeFree | Detail | |
<0.001 | sarcoidosis | NA | BeFree | Detail | |
<0.001 | Kaposi sarcoma | NA | BeFree | Detail | |
<0.001 | schistosomiasis | NA | BeFree | Detail | |
0.002 | systemic scleroderma | Genotype-mRNA expression correlation analysis revealed that the IRF8 protective ... | BeFree | 25880423 | Detail |
<0.001 | Skin lesion | The fact that treatment with recombinant type I IFNs (α and β) can induce not on... | BeFree | 24420508 | Detail |
<0.001 | Skin lesion | In contrast, other antimicrobial peptides expressed in psoriatic skin including ... | BeFree | 25332209 | Detail |
<0.001 | Skin Neoplasms | Delivery of DNA vaccines encoding XBP1 and tumor Ag to skin DC resulted in incre... | BeFree | 25972487 | Detail |
<0.001 | ankylosing spondylitis | NA | BeFree | Detail | |
<0.001 | Superinfection | NA | BeFree | Detail | |
<0.001 | Giant Cell Arteritis | NA | BeFree | Detail | |
<0.001 | tetanus | NA | BeFree | Detail | |
<0.001 | Thrombocythemia, Essential | NA | BeFree | Detail | |
<0.001 | thyroiditis | NA | BeFree | Detail | |
<0.001 | thyrotoxicosis | NA | BeFree | Detail | |
<0.001 | Trisomy | NA | BeFree | Detail | |
<0.001 | Chagas disease | NA | BeFree | Detail | |
<0.001 | tuberculosis | NA | BeFree | Detail | |
<0.001 | uveitis | NA | BeFree | Detail | |
<0.001 | viral hepatitis | NA | BeFree | Detail | |
0.001 | Viremia | NA | BeFree | Detail | |
<0.001 | vitiligo | NA | BeFree | Detail | |
<0.001 | Wiskott-Aldrich syndrome | NA | BeFree | Detail | |
<0.001 | yellow fever | Here we show that yellow fever virus (YFV) inhibits IFN-I signaling through a un... | BeFree | 25211074 | Detail |
<0.001 | Fibromatosis, Aggressive | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
<0.001 | diffuse large B-cell lymphoma | In DLBCL cell lines, CC-122-induced degradation or short hairpin RNA-mediated kn... | BeFree | 26002965 | Detail |
<0.001 | T-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | Lymphoma, T-Cell, Cutaneous | NA | BeFree | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | Li-Fraumeni syndrome | NA | BeFree | Detail | |
<0.001 | Encephalopathies | Aicardi-Goutières syndrome (AGS) is an autosomal-recessive encephalopathy in chi... | BeFree | 25500879 | Detail |
<0.001 | Encephalopathies | In humans, loss of function mutations in the SAMHD1 (AGS5) gene cause a severe f... | BeFree | 25672750 | Detail |
<0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Polyglandular Type I Autoimmune Syndrome | NA | BeFree | Detail | |
<0.001 | Depressive Symptoms | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Cutaneous Melanoma | NA | BeFree | Detail | |
<0.001 | Idiopathic pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | allergic asthma | NA | BeFree | Detail | |
<0.001 | intrinsic asthma | NA | BeFree | Detail | |
<0.001 | Right Ventricular Hypertrophy | NA | BeFree | Detail | |
<0.001 | Cicatrix, Hypertrophic | NA | BeFree | Detail | |
<0.001 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | Diabetes, Autoimmune | NA | BeFree | Detail | |
<0.001 | Dysplastic Nevus | NA | BeFree | Detail | |
<0.001 | Lung Diseases, Interstitial | NA | BeFree | Detail | |
<0.001 | Idiopathic hypereosinophilic syndrome | NA | BeFree | Detail | |
<0.001 | Cervical Intraepithelial Neoplasia | The objective of this study was to evaluate the production of cytokines in helpe... | BeFree | 25764160 | Detail |
<0.001 | Rhabdoid Tumor | NA | BeFree | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
0.001 | Adult type dermatomyositis | NA | BeFree | Detail | |
<0.001 | Paresthesia, Distal | NA | BeFree | Detail | |
0.002 | pancreatic carcinoma | Human pancreatic cancer cell lines variably respond to IFN-α and -β. | BeFree | 24460759 | Detail |
0.002 | pancreatic carcinoma | A few years ago in vitro, in vivo, and several clinical trials have been describ... | BeFree | 25551196 | Detail |
<0.001 | Female Pseudohermaphroditism | NA | BeFree | Detail | |
<0.001 | Anemia, severe | NA | BeFree | Detail | |
<0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
<0.001 | Hepatitis, Autoimmune | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of lung | NA | BeFree | Detail | |
0.031 | Hepatitis C, Chronic | The SNPs rs738409478 and rs2645424 were determined by real-time PCR in 478 patie... | BeFree | 23870067 | Detail |
<0.001 | Drug usage | NA | BeFree | Detail | |
<0.001 | Parasitemia | NA | BeFree | Detail | |
<0.001 | viral encephalitis | NA | BeFree | Detail | |
<0.001 | disseminated eosinophilic collagen disease | NA | BeFree | Detail | |
0.002 | Vesicular Stomatitis | In transfected bovine fetal fibroblasts, expression of intracellular IFN-α induc... | BeFree | 25004008 | Detail |
0.002 | Vesicular Stomatitis | Since pDC, but not cDC, from pearl mice showed an impaired IFN-α and tumor necro... | BeFree | 25333950 | Detail |
0.002 | Vesicular Stomatitis | Therefore, IFN-α and -β differentially affect VSV oncolysis, justifying the eval... | BeFree | 25995245 | Detail |
0.002 | Vesicular Stomatitis | We found that TLR3-ligand polyinosinic-polycytidylic acid and human rhinovirus i... | BeFree | 26101320 | Detail |
0.003 | Coinfection | The OPERA study results show that PEG-IFN plus ribavirin is an effective treatme... | BeFree | 24583976 | Detail |
<0.001 | Viral myocarditis | NA | BeFree | Detail | |
<0.001 | Herpes encephalitis | NA | BeFree | Detail | |
<0.001 | Disease due to Parvoviridae | Pancreatic adenocarcinoma upregulated factor (PAUF) confers resistance to pancre... | BeFree | 25727013 | Detail |
0.002 | Respiratory syncytial virus bronchiolitis | NA | GAD | Detail | |
0.001 | Chronic viral hepatitis | The induction of TLR7 responsiveness of monocytes by IFNα in vivo in HCV patient... | BeFree | 25014880 | Detail |
<0.001 | Metastatic Renal Cell Cancer | NA | BeFree | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
<0.001 | Philadelphia chromosome positive chronic myelogenous leukemia | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
<0.001 | Transitional cell carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | Iron Overload | NA | BeFree | Detail | |
<0.001 | Tumor necrosis | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
<0.001 | Impaired cognition | NA | BeFree | Detail | |
<0.001 | Stable angina | NA | BeFree | Detail | |
<0.001 | Chronic liver disease | Of 326 patients with HCV-related chronic liver disease (252 with genotype 1b and... | BeFree | 24065124 | Detail |
<0.001 | Specific viral infections | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | malignant mesothelioma | NA | BeFree | Detail | |
<0.001 | chronic eosinophilic leukemia | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of pancreas | Human pancreatic cancer cell lines variably respond to IFN-α and -β. | BeFree | 24460759 | Detail |
0.002 | Malignant neoplasm of pancreas | A few years ago in vitro, in vivo, and several clinical trials have been describ... | BeFree | 25551196 | Detail |
<0.001 | Asthma attack | Additionally, individuals with asthma who are infected with HCV and respond to I... | BeFree | 26026068 | Detail |
<0.001 | Malignant neoplasm of central nervous system | NA | BeFree | Detail | |
<0.001 | Cervical intraepithelial neoplasia grade 2 | We conducted a prospective study with 17 patients with CIN II-III using immunoth... | BeFree | 25764160 | Detail |
<0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.002 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | Viral non-structural proteins NS1 and NS2 are critically required for RSV virule... | BeFree | 24992002 | Detail |
0.002 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | In order to explore the interactions between the IFN pathway and human respirato... | BeFree | 25228491 | Detail |
<0.001 | dengue shock syndrome | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of prostate | Additional studies will be required to fully establish the cross-talk between an... | BeFree | 25327819 | Detail |
<0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
<0.001 | Aicardi-Goutieres syndrome | In humans, loss of function mutations in the SAMHD1 (AGS5) gene cause a severe f... | BeFree | 25672750 | Detail |
<0.001 | thrombophilia | NA | BeFree | Detail | |
0.007 | lupus erythematosus | The fact that treatment with recombinant type I IFNs (α and β) can induce not on... | BeFree | 24420508 | Detail |
0.007 | lupus erythematosus | Persistent production of IFN-α, the most abundant subtype measured in these pati... | BeFree | 25468480 | Detail |
<0.001 | Disseminated due to other mycobacteria | NA | BeFree | Detail | |
<0.001 | Chronic active hepatitis | NA | BeFree | Detail | |
0.008 | Hepatitis B, Chronic | Peginterferon α (PEG-IFN), which includes PEG-IFN α-2a (Pegasys) and PEG-IFN α-2... | BeFree | 24738850 | Detail |
0.008 | Hepatitis B, Chronic | We retrospectively enrolled 190 patients with chronic hepatitis B HBeAg negative... | BeFree | 25060765 | Detail |
0.008 | Hepatitis B, Chronic | Indeed, IFN-α has been successfully used for treatment of patients with chronic ... | BeFree | 25206268 | Detail |
0.008 | Hepatitis B, Chronic | Here, a study was conducted to investigate the dynamic changes in phenotype and ... | BeFree | 25774808 | Detail |
<0.001 | Mixed cryoglobulinemia | Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cry... | BeFree | 26060059 | Detail |
<0.001 | Malignant neoplasm of esophagus | NA | BeFree | Detail | |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant epithelioma | NA | BeFree | Detail | |
0.001 | Malignant glioma | IFN-DC of patients with malignant gliomas were characterized by low chemotaxis i... | BeFree | 25894778 | Detail |
0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
<0.001 | Carcinogenesis | NA | BeFree | Detail | |
0.001 | prostate carcinoma | Additional studies will be required to fully establish the cross-talk between an... | BeFree | 25327819 | Detail |
<0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
0.003 | breast carcinoma | NA | BeFree | Detail | |
0.001 | Carcinoma of lung | NA | BeFree | Detail | |
0.002 | colon carcinoma | NA | BeFree | Detail | |
<0.001 | stomach carcinoma | NA | BeFree | Detail | |
0.002 | Carcinoma of bladder | NA | BeFree | Detail | |
0.002 | Central neuroblastoma | Delayed IFN response differentiates replication of West Nile virus and Japanese ... | BeFree | 25920530 | Detail |
<0.001 | Varicella zoster | Conversely, VZV infection in keratinocytes (HaCaT) resulted in a persistent incr... | BeFree | 26072679 | Detail |
<0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
<0.001 | AIDS defining illness | After multivariate analyses the independent positive predictors for SVR after tr... | BeFree | 25181403 | Detail |
<0.001 | Multiple Sclerosis, Relapsing-Remitting | NA | BeFree | Detail | |
0.001 | Aicardi-Goutieres syndrome 1 | Aicardi-Goutières syndrome (AGS) is an autosomal-recessive encephalopathy in chi... | BeFree | 25500879 | Detail |
0.001 | Aicardi-Goutieres syndrome 1 | In humans, loss of function mutations in the SAMHD1 (AGS5) gene cause a severe f... | BeFree | 25672750 | Detail |
<0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
<0.001 | thrombocytosis | NA | BeFree | Detail | |
<0.001 | Myocarditis, chronic | NA | BeFree | Detail | |
<0.001 | Acute coronary syndrome | NA | BeFree | Detail | |
<0.001 | Primary infection NOS | NA | BeFree | Detail | |
<0.001 | Ovarian adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Colorectal cancer metastatic | NA | BeFree | Detail | |
<0.001 | Spondylarthritis | NA | BeFree | Detail | |
<0.001 | West Nile viral infection | Delayed IFN response differentiates replication of West Nile virus and Japanese ... | BeFree | 25920530 | Detail |
<0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
<0.001 | Primary HIV infection | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the head and neck | Differential responsiveness of tumor cells to IFN-α and -β was further supported... | BeFree | 25995245 | Detail |
0.002 | severe acute respiratory syndrome | Through our genomics-based approach, we found topological differences in the kin... | BeFree | 25534508 | Detail |
0.001 | sarcoma | NA | BeFree | Detail | |
<0.001 | Persistent infection | NA | BeFree | Detail | |
<0.001 | Cutaneous lymphoma | NA | BeFree | Detail | |
<0.001 | Inflammatory disorder | Finally, the broader role of IFN-λ in the immunopathogenesis of non-infectious i... | BeFree | 25634147 | Detail |
<0.001 | Inflammatory disorder | IFN-α production by plasmacytoid dendritic cell associations with polymorphisms ... | BeFree | 25779693 | Detail |
<0.001 | Chronic myeloproliferative disorder | In recent years, major molecular remissions have been observed in patients with ... | BeFree | 25082025 | Detail |
<0.001 | Single tumor | NA | BeFree | Detail | |
<0.001 | Eosinophilic disorder | NA | BeFree | Detail | |
<0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
0.001 | Carcinoma of urinary bladder, superficial | NA | BeFree | Detail | |
<0.001 | Treatment-Induced Anemia | NA | BeFree | Detail | |
<0.001 | Epithelioma | NA | BeFree | Detail | |
<0.001 | mature teratoma | NA | BeFree | Detail | |
<0.001 | renal carcinoma | NA | BeFree | Detail | |
<0.001 | Systemic onset juvenile chronic arthritis | NA | BeFree | Detail | |
<0.001 | Vascular lesions | NA | BeFree | Detail | |
<0.001 | Mammary Neoplasms | NA | BeFree | Detail | |
<0.001 | Primary Glioblastoma | NA | BeFree | Detail | |
<0.001 | Tumor Immunity | In the present work, we hypothesized that engineering easily generated human mon... | BeFree | 25863943 | Detail |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
<0.001 | colorectal cancer | NA | BeFree | Detail | |
<0.001 | hypereosinophilic syndrome | NA | BeFree | Detail | |
<0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
0.005 | Cirrhosis | Of 326 patients with HCV-related chronic liver disease (252 with genotype 1b and... | BeFree | 24065124 | Detail |
0.005 | Cirrhosis | The recent October 2014 approval of the fixed dose combination (FDC) of the NS5B... | BeFree | 25676581 | Detail |
<0.001 | Disorder characterized by eosinophilia | NA | BeFree | Detail | |
<0.001 | tumor vasculature | NA | BeFree | Detail | |
<0.001 | Recurrent infections (sinusitis and bacterial pneumonia and meningitis) | Thus, identification of these SNPs may be useful to predict the response to IFN-... | BeFree | 25938745 | Detail |
<0.001 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | NA | BeFree | Detail | |
<0.001 | Craniometaphyseal dysplasia, autosomal dominant | NA | BeFree | Detail | |
<0.001 | coronary artery disease | The results argue against the potential utility of drugs targeting type-I IFN pr... | BeFree | 25882064 | Detail |
0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree | Detail | |
0.006 | liver carcinoma | Here, we report that the IFN-α-induced microRNA-26a (miR-26a) can inhibit HCC pr... | BeFree | 25494962 | Detail |
<0.001 | Allergic rhinitis (disorder) | NA | BeFree | Detail | |
<0.001 | MYD88 Deficiency | NA | BeFree | Detail | |
<0.001 | Steatohepatitis | Hepatic steatosis is a risk factor for both liver disease progression and an imp... | BeFree | 25961570 | Detail |
0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
<0.001 | Mechanical Allodynia | NA | BeFree | Detail | |
<0.001 | Tuberculous pleural effusion | NA | BeFree | Detail | |
<0.001 | Pulmonary arterial hypertension | NA | BeFree | Detail | |
<0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
<0.001 | Autoimmune polyendocrinopathy syndrome, type 1 | NA | BeFree | Detail | |
<0.001 | Allergic disposition | NA | BeFree | Detail | |
<0.001 | Allergic sensitization | NA | BeFree | Detail | |
<0.001 | Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia | NA | BeFree | Detail | |
<0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Adenovirus Infections | NA | BeFree | Detail | |
<0.001 | Primary myelofibrosis | NA | BeFree | Detail | |
0.002 | anemia | Polymorphisms at the SLC29A1 gene, encoding ENT1, may influence ribavirin-associ... | BeFree | 25583751 | Detail |
<0.001 | Angina, Unstable | NA | BeFree | Detail | |
<0.001 | Anorexia | PEG-IFN/RBV/TVR therapy yielded high SVR rates, but it was associated with a dec... | BeFree | 25400176 | Detail |
0.001 | arteriosclerosis | Patients with systemic lupus erythematosus are genetically predisposed to enhanc... | BeFree | 25882064 | Detail |
0.001 | arthritis | NA | BeFree | Detail | |
0.002 | rheumatoid arthritis | NA | BeFree | Detail | |
0.005 | asthma | Multiple deficiencies in the innate immune response to HRV were identified in as... | BeFree,GAD | 25203745 | Detail |
0.005 | asthma | The role of macrophage IL-10/innate IFN interplay during virus-induced asthma. | BeFree,GAD | 25430775 | Detail |
0.005 | asthma | Rhinovirus infections are the dominant cause of asthma exacerbations, and defici... | BeFree,GAD | 25630941 | Detail |
0.005 | asthma | Additionally, individuals with asthma who are infected with HCV and respond to I... | BeFree,GAD | 26026068 | Detail |
0.001 | atherosclerosis | Patients with systemic lupus erythematosus are genetically predisposed to enhanc... | BeFree | 25882064 | Detail |
0.007 | Autoimmune Diseases | We investigated whether single-nucleotide polymorphisms (SNPs) associated with S... | BeFree | 25779693 | Detail |
0.007 | Autoimmune Diseases | Trex1 (-/-) mice develop lethal, IFN-driven autoimmune disease that is dependent... | BeFree | 26223655 | Detail |
<0.001 | Melanoma, B16 | NA | BeFree | Detail | |
<0.001 | Behcet Syndrome | NA | BeFree | Detail | |
<0.001 | bipolar disorder | As a result, IL-6, IL-8 and IFN related pathways held twice to thrice the number... | BeFree | 25855618 | Detail |
0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
<0.001 | Blast Phase | NA | BeFree | Detail | |
<0.001 | Blood Coagulation Disorders | NA | BeFree | Detail | |
<0.001 | Bone Diseases | NA | BeFree | Detail | |
<0.001 | Brain Neoplasms | We compared migration activities of IFN-α- and IL-4-induced dendritic cells (IFN... | BeFree | 25894778 | Detail |
0.003 | Malignant neoplasm of breast | NA | BeFree | Detail | |
0.002 | Bronchiolitis, Viral | NA | GAD | Detail | |
<0.001 | brucellosis | NA | BeFree | Detail | |
<0.001 | Burkitt lymphoma | NA | BeFree | Detail | |
0.002 | Malignant tumor of colon | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of prostate | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
<0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
0.003 | renal cell carcinoma | Gene therapy using this IFN-α2b gene construct with HREs may represent a novel t... | BeFree | 23739923 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results argue against the potential utility of drugs targeting type-I IFN production for coronar... | DisGeNET | Detail |
The results argue against the potential utility of drugs targeting type-I IFN production for coronar... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We showed that DC are the primary producers of type I interferons (T1-IFN), requisite cytokines for ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Delayed IFN response differentiates replication of West Nile virus and Japanese encephalitis virus i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results suggest that enterovirus-induced miR-146a facilitates viral pathogenesis by suppressing ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hepatic steatosis is a risk factor for both liver disease progression and an impaired response to in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We have previously shown that cysteine-rich 61 protein (CCN1) activates a type 1 IFN antiviral defen... | DisGeNET | Detail |
Delayed IFN response differentiates replication of West Nile virus and Japanese encephalitis virus i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Those with mild HFMD had higher γ-IFN expression levels compared with those with severe HFMD (P < 0.... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The identification of mutations in the HVR1 region of hepatitis type C virus (HCV) is time-consuming... | DisGeNET | Detail |
The identification of mutations in the HVR1 region of hepatitis type C virus (HCV) is time-consuming... | DisGeNET | Detail |
For HBeAg-positive patients and HBeAg-negative patients with genotype D infection, PEG-IFN therapy c... | DisGeNET | Detail |
The study of on-treatment dynamics of HBV infection by means of combined quantitative monitoring of ... | DisGeNET | Detail |
Then, we aimed to investigate the role of CYP27B1 polymorphisms in HBV treatment with PEG-IFN. | DisGeNET | Detail |
A total of 30 patients with CHB who achieved HBsAg seroclearance following peg-IFN-α therapy and an ... | DisGeNET | Detail |
In SVR to Peg-IFN/NUCs MiR-B-Index improved during-therapy and post-treatment reaching IC-like value... | DisGeNET | Detail |
A total of 210 patients with chronic hepatitis C genotype 1 of high viral load (baseline serum hepat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The next phase of therapy will be combining several classes of DAAs without IFN in order to make sus... | DisGeNET | Detail |
For patients infected with hepatitis C virus (HCV), the combination of the direct-acting antiviral a... | DisGeNET | Detail |
In addition, the results suggest new viral genomic attributes that might influence the outcome of IF... | DisGeNET | Detail |
Noncirrhotic HCV treatment-naive patients and prior relapsers received response-guided therapy (RGT)... | DisGeNET | Detail |
Optimizing triple therapy and IFN/RBV-free regimens for hepatitis C virus infection. | DisGeNET | Detail |
In May 2011, boceprevir and telaprevir, two first-generation NS3/4A protease inhibitors, were approv... | DisGeNET | Detail |
Treatment of hepatitis C virus (HCV) with pegylated interferon and ribavirin (IFN/RBV) can be associ... | DisGeNET | Detail |
This review will focus on the second-wave DAAs including protease inhibitors (PI), nucleotide inhibi... | DisGeNET | Detail |
Forty patients infected with hepatitis C virus (HCV) genotype 1 and starting anti-HCV therapy with t... | DisGeNET | Detail |
Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children. | DisGeNET | Detail |
Impaired induction of IL28B, related to IFNλ4 expression in PBMCs of IL28B-unfavorable patients, is ... | DisGeNET | Detail |
Here, we discuss IFN-λ genetic polymorphisms and their role in HCV and other infectious diseases as ... | DisGeNET | Detail |
IFN-free regimens with direct antiviral agents (DAAs) against hepatitis C virus (HCV) are likely to ... | DisGeNET | Detail |
Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplan... | DisGeNET | Detail |
In this contest IFN-α therapy, a standard therapy for HCV-infection and lymphoproliferative diseases... | DisGeNET | Detail |
These findings expand our understanding of IFN-responses in HCV-infected individuals and suggest tha... | DisGeNET | Detail |
We conducted an open-label trial to assess the efficacy and safety of sofosbuvir (SOF) plus pegylate... | DisGeNET | Detail |
Between January 2006 and June 2012, a total of 180 patients with chronic infections of G2 hepatitis ... | DisGeNET | Detail |
A total of 210 patients with chronic hepatitis C genotype 1 of high viral load (baseline serum hepat... | DisGeNET | Detail |
Hepatitis C virus (HCV) genotype 1 infections are significantly more difficult to eradicate with PEG... | DisGeNET | Detail |
To assess the accuracy and cost-effectiveness of the automated Abbott ARCHITECT HCV Ag assay (Wiesba... | DisGeNET | Detail |
We demonstrated a marked polarization of NK cells toward cytotoxicity in response to IFN-α stimulati... | DisGeNET | Detail |
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and re... | DisGeNET | Detail |
Sixty-one patients under suppressive antiretroviral therapy were included: 37 with hepatitis C virus... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The OPERA study results show that PEG-IFN plus ribavirin is an effective treatment for HCV-HIV coinf... | DisGeNET | Detail |
We modeled increased activation in HIV infection by priming human monocytes with IFNα followed by ex... | DisGeNET | Detail |
To determine SVR and other response rates, identify SVR predictors and analyse differences between G... | DisGeNET | Detail |
The specific reduction of miR-422a is associated with exogenous IFN-α treatment, and likely contribu... | DisGeNET | Detail |
In sum, we identified a novel mechanism of HIV-1-induced CXCL13 secretion-one caused by TLR7 inducti... | DisGeNET | Detail |
Blimp-1 binds an IFN-stimulated response element within HIV-1 provirus, and it is displaced followin... | DisGeNET | Detail |
The results suggest that the presence of the IFN+874A allele confers susceptibility to HIV-1 infecti... | DisGeNET | Detail |
Group 1 comprised HIV/HCV co-infected patients who were treated with highly active antiretroviral th... | DisGeNET | Detail |
These novel findings will be of great interest to those working on the roles of IFN and pDCs in HIV-... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The increased level of IFN-λ mRNA corresponded to significantly increased level of RIG-1 mRNA. shRNA... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Logistic regression analysis showed that rs2305482 CC and neutrophil count at baseline were independ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Of 326 patients with HCV-related chronic liver disease (252 with genotype 1b and 74 with genotype 2a... | DisGeNET | Detail |
The recent October 2014 approval of the fixed dose combination (FDC) of the NS5B polymerase inhibito... | DisGeNET | Detail |
Hepatic steatosis is a risk factor for both liver disease progression and an impaired response to in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Persistent production of IFN-α, the most abundant subtype measured in these patients, is an importan... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Persistent production of IFN-α, the most abundant subtype measured in these patients, is an importan... | DisGeNET | Detail |
NA | DisGeNET | Detail |
RST1 isolates, which are more frequently associated with disseminated Lyme disease in humans and mic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this contest IFN-α therapy, a standard therapy for HCV-infection and lymphoproliferative diseases... | DisGeNET | Detail |
Interferon-γ (IFNG) microsatellite repeat and single nucleotide polymorphism haplotypes of IFN-α rec... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expression of the IFITM proteins was found to delay the phosphorylation of IFN regulatory factor 3 t... | DisGeNET | Detail |
Baseline expression of PD-L1 by melanoma cell lines was virtually nil, regardless of BRAFmut status,... | DisGeNET | Detail |
Serum samples from 275 high-risk melanoma patients enrolled in the Nordic Adjuvant IFN Melanoma tria... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function. | DisGeNET | Detail |
Induction of IFN-α subtypes and their antiviral activity in mumps virus infection. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Conversely, the IFN metagene was associated with a low risk of metastasis in 104 ERBB2+ tumors (P = ... | DisGeNET | Detail |
These results provide evidence supporting that EMT activation and IFN pathway inactivation are marke... | DisGeNET | Detail |
Overall, our findings describe a novel role for IFN during metastasis development and suggest that n... | DisGeNET | Detail |
Delayed IFN response differentiates replication of West Nile virus and Japanese encephalitis virus i... | DisGeNET | Detail |
Logistic regression analysis showed that rs2305482 CC and neutrophil count at baseline were independ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Uniformly low expression of IFN and IFNGR1 in PKDL skin biopsies could explain parasite persistence ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In contrast, other antimicrobial peptides expressed in psoriatic skin including elafin, hBD1, and ps... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, knocking down the endogenous and IFN-induced expression of IFITM1 and 3 facilitated RSV... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genotype-mRNA expression correlation analysis revealed that the IRF8 protective allele was associate... | DisGeNET | Detail |
The fact that treatment with recombinant type I IFNs (α and β) can induce not only systemic organ ma... | DisGeNET | Detail |
In contrast, other antimicrobial peptides expressed in psoriatic skin including elafin, hBD1, and ps... | DisGeNET | Detail |
Delivery of DNA vaccines encoding XBP1 and tumor Ag to skin DC resulted in increased IFN-α productio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here we show that yellow fever virus (YFV) inhibits IFN-I signaling through a unique mechanism that ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In DLBCL cell lines, CC-122-induced degradation or short hairpin RNA-mediated knockdown of Aiolos an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Aicardi-Goutières syndrome (AGS) is an autosomal-recessive encephalopathy in children that is charac... | DisGeNET | Detail |
In humans, loss of function mutations in the SAMHD1 (AGS5) gene cause a severe form of Aicardi-Gouti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The objective of this study was to evaluate the production of cytokines in helper T (CD4+) lymphocyt... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Human pancreatic cancer cell lines variably respond to IFN-α and -β. | DisGeNET | Detail |
A few years ago in vitro, in vivo, and several clinical trials have been described regarding adjuvan... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The SNPs rs738409478 and rs2645424 were determined by real-time PCR in 478 patients with CHC (m/f: 3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In transfected bovine fetal fibroblasts, expression of intracellular IFN-α induced resistance to ves... | DisGeNET | Detail |
Since pDC, but not cDC, from pearl mice showed an impaired IFN-α and tumor necrosis factor-α product... | DisGeNET | Detail |
Therefore, IFN-α and -β differentially affect VSV oncolysis, justifying the evaluation and compariso... | DisGeNET | Detail |
We found that TLR3-ligand polyinosinic-polycytidylic acid and human rhinovirus infection induced a p... | DisGeNET | Detail |
The OPERA study results show that PEG-IFN plus ribavirin is an effective treatment for HCV-HIV coinf... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Pancreatic adenocarcinoma upregulated factor (PAUF) confers resistance to pancreatic cancer cells ag... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The induction of TLR7 responsiveness of monocytes by IFNα in vivo in HCV patients is relevant for th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Of 326 patients with HCV-related chronic liver disease (252 with genotype 1b and 74 with genotype 2a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Human pancreatic cancer cell lines variably respond to IFN-α and -β. | DisGeNET | Detail |
A few years ago in vitro, in vivo, and several clinical trials have been described regarding adjuvan... | DisGeNET | Detail |
Additionally, individuals with asthma who are infected with HCV and respond to IFN therapy showed a ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We conducted a prospective study with 17 patients with CIN II-III using immunotherapy with pegylated... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Viral non-structural proteins NS1 and NS2 are critically required for RSV virulence; they strongly s... | DisGeNET | Detail |
In order to explore the interactions between the IFN pathway and human respiratory syncytial virus (... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Additional studies will be required to fully establish the cross-talk between androgen receptor-IFN ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In humans, loss of function mutations in the SAMHD1 (AGS5) gene cause a severe form of Aicardi-Gouti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The fact that treatment with recombinant type I IFNs (α and β) can induce not only systemic organ ma... | DisGeNET | Detail |
Persistent production of IFN-α, the most abundant subtype measured in these patients, is an importan... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Peginterferon α (PEG-IFN), which includes PEG-IFN α-2a (Pegasys) and PEG-IFN α-2b (Peg-Intron), can ... | DisGeNET | Detail |
We retrospectively enrolled 190 patients with chronic hepatitis B HBeAg negative treated for 48 week... | DisGeNET | Detail |
Indeed, IFN-α has been successfully used for treatment of patients with chronic hepatitis B. | DisGeNET | Detail |
Here, a study was conducted to investigate the dynamic changes in phenotype and function of peripher... | DisGeNET | Detail |
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and re... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IFN-DC of patients with malignant gliomas were characterized by low chemotaxis in response to CCL19 ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Additional studies will be required to fully establish the cross-talk between androgen receptor-IFN ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Delayed IFN response differentiates replication of West Nile virus and Japanese encephalitis virus i... | DisGeNET | Detail |
Conversely, VZV infection in keratinocytes (HaCaT) resulted in a persistent increase in type I IFN g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
After multivariate analyses the independent positive predictors for SVR after treatment for chronic ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Aicardi-Goutières syndrome (AGS) is an autosomal-recessive encephalopathy in children that is charac... | DisGeNET | Detail |
In humans, loss of function mutations in the SAMHD1 (AGS5) gene cause a severe form of Aicardi-Gouti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Delayed IFN response differentiates replication of West Nile virus and Japanese encephalitis virus i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Differential responsiveness of tumor cells to IFN-α and -β was further supported by the finding that... | DisGeNET | Detail |
Through our genomics-based approach, we found topological differences in the kinetics and magnitude ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Finally, the broader role of IFN-λ in the immunopathogenesis of non-infectious inflammatory diseases... | DisGeNET | Detail |
IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related... | DisGeNET | Detail |
In recent years, major molecular remissions have been observed in patients with JAK2-positive chroni... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the present work, we hypothesized that engineering easily generated human monocyte-derived mature... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Of 326 patients with HCV-related chronic liver disease (252 with genotype 1b and 74 with genotype 2a... | DisGeNET | Detail |
The recent October 2014 approval of the fixed dose combination (FDC) of the NS5B polymerase inhibito... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thus, identification of these SNPs may be useful to predict the response to IFN-based therapy of HCV... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results argue against the potential utility of drugs targeting type-I IFN production for coronar... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we report that the IFN-α-induced microRNA-26a (miR-26a) can inhibit HCC proliferation and inva... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hepatic steatosis is a risk factor for both liver disease progression and an impaired response to in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Polymorphisms at the SLC29A1 gene, encoding ENT1, may influence ribavirin-associated anaemia, which ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
PEG-IFN/RBV/TVR therapy yielded high SVR rates, but it was associated with a decreased body weight d... | DisGeNET | Detail |
Patients with systemic lupus erythematosus are genetically predisposed to enhanced production of the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Multiple deficiencies in the innate immune response to HRV were identified in asthma, with significa... | DisGeNET | Detail |
The role of macrophage IL-10/innate IFN interplay during virus-induced asthma. | DisGeNET | Detail |
Rhinovirus infections are the dominant cause of asthma exacerbations, and deficient virus induction ... | DisGeNET | Detail |
Additionally, individuals with asthma who are infected with HCV and respond to IFN therapy showed a ... | DisGeNET | Detail |
Patients with systemic lupus erythematosus are genetically predisposed to enhanced production of the... | DisGeNET | Detail |
We investigated whether single-nucleotide polymorphisms (SNPs) associated with SLE and other autoimm... | DisGeNET | Detail |
Trex1 (-/-) mice develop lethal, IFN-driven autoimmune disease that is dependent on activation of th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
As a result, IL-6, IL-8 and IFN related pathways held twice to thrice the number of expected variant... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We compared migration activities of IFN-α- and IL-4-induced dendritic cells (IFN-DC and IL4-DC) gene... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Gene therapy using this IFN-α2b gene construct with HREs may represent a novel treatment modality fo... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs738409478 dbSNP
- Genome
- hg38
- Position
- chr9:21,367,372-21,368,057
- Variant Type
- snv
Genome browser